Building a national framework for the establishment of regulatory science for drug development

Rubriek: Textual/Printed/Reference Materials - Boek

Prijs: € 25.99

Rating: 0/5

☆

☆

☆

☆

☆

Verzending:
2 - 3 weken

The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it.

• 1 Bekijk alle specificaties

Oorspronkelijke releasedatum: 15 maart 2011

Aantal pagina's: 94

Hoofdauteur: Board On Health Sciences Policy

Tweede Auteur: Forum on Drug Discovery, Development, and Translation

Co Auteur: Board On Health Sciences Policy

Hoofdredacteur: Yeonwoo Lebovitz

Tweede Redacteur: Rebecca English

Co Redacteur: Anne Claiborne

Hoofduitgeverij: National Academies Press

Editie: 1

Verpakking breedte: 152 mm

Verpakking hoogte: 229 mm

Verpakking lengte: 229 mm

Verpakkingsgewicht: 163 g

EAN: 9780309158893

---